618EGP
- Active ingredient
- insulin degludec+insulin aspart
- Strength
- 100i.u./ml
- Form
- pen
- Manufacturer
- novo nordisk
- Route
- injection
Uses
Used to improve glycemic control in adults with diabetes mellitus.
Do not use if
Hypoglycemia or hypersensitivity to the formulation.
Side effects
Hypoglycemia, injection-site reactions, and weight gain may occur.
Warnings
Monitor blood glucose regularly and adjust therapy as needed.
How it works
Combines rapid-acting insulin aspart with ultra-long-acting insulin degludec.
Storage
Store refrigerated before use. Do not freeze.
